What is the current valuation of the UK Epilepsy Surgery Market?

The UK Epilepsy Surgery Market was valued at 78.12 USD Million in 2024. Read More

What is the projected market valuation for the UK Epilepsy Surgery Market by 2035?

The market is projected to reach 138.6 USD Million by 2035. Read More

What is the expected CAGR for the UK Epilepsy Surgery Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 5.35%. Read More

Which surgical procedure types dominate the UK Epilepsy Surgery Market?

Resective Surgery, Functional Surgery, and Laser Surgery are key segments, with Resective Surgery valued between 30.0 and 55.0 USD Million. Read More

How does the market perform in terms of patient demographics?

The market for Adult Patients is projected between 40.0 and 70.0 USD Million, indicating a strong focus on this demographic. Read More

What are the leading technologies in the UK Epilepsy Surgery Market?

Neurostimulation Devices and Surgical Navigation Systems are leading technologies, with Neurostimulation Devices valued between 30.0 and 55.0 USD Million. Read More

Which healthcare settings are most significant in the UK Epilepsy Surgery Market?

Hospitals and Specialized Epilepsy Centers are crucial, with Hospitals valued between 30.0 and 55.0 USD Million. Read More

What types of epilepsy are primarily addressed in the market?

The market addresses Drug-Resistant Epilepsy and Focal Epilepsy, with Drug-Resistant Epilepsy valued between 30.0 and 55.0 USD Million. Read More

Who are the key players in the UK Epilepsy Surgery Market?

Key players include Medtronic, Boston Scientific, and Abbott Laboratories, among others. Read More

What trends are anticipated in the UK Epilepsy Surgery Market by 2035?

The market is likely to expand, driven by advancements in technology and increasing patient awareness. Read More

UK Epilepsy Surgery Market

ID: MRFR/HC/51350-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

UK Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)) and By End User (Hospitals & Clinics, Specialty Centers) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Surgical Procedure Type (USD Million)
  1. 4.1.1 Resective Surgery
  2. 4.1.2 Functional Surgery
  3. 4.1.3 Laser Surgery
  4. 4.1.4 Hemispherectomy
2. 4.2 Healthcare, BY Indication (USD Million)
  1. 4.2.1 Drug-Resistant Epilepsy
  2. 4.2.2 Focal Epilepsy
  3. 4.2.3 Generalized Epilepsy
  4. 4.2.4 Neurodegenerative Disorders
3. 4.3 Healthcare, BY Patient Demographics (USD Million)
  1. 4.3.1 Pediatric Patients
  2. 4.3.2 Adult Patients
  3. 4.3.3 Geriatric Patients
4. 4.4 Healthcare, BY Technology (USD Million)
  1. 4.4.1 Neurostimulation Devices
  2. 4.4.2 Surgical Navigation Systems
  3. 4.4.3 Imaging Techniques
  4. 4.4.4 Robotic Surgery
5. 4.5 Healthcare, BY Healthcare Setting (USD Million)
  1. 4.5.1 Hospitals
  2. 4.5.2 Specialized Epilepsy Centers
  3. 4.5.3 Outpatient Clinics
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 NeuroPace (GB)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Johnson & Johnson (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 LivaNova (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cleveland Clinic (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Epilepsy Society (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE
3. 6.3 UK MARKET ANALYSIS BY INDICATION
4. 6.4 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
5. 6.5 UK MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 UK MARKET ANALYSIS BY HEALTHCARE SETTING
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SURGICAL PROCEDURE TYPE, 2026-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2026-2035 (USD Million)
  3. 7.2.3 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
  5. 7.2.5 BY HEALTHCARE SETTING, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Healthcare Market Segmentation

Healthcare By Surgical Procedure Type (USD Million, 2026-2035)

Resective Surgery
Functional Surgery
Laser Surgery
Hemispherectomy

Healthcare By Indication (USD Million, 2026-2035)

Drug-Resistant Epilepsy
Focal Epilepsy
Generalized Epilepsy
Neurodegenerative Disorders

Healthcare By Patient Demographics (USD Million, 2026-2035)

Pediatric Patients
Adult Patients
Geriatric Patients

Healthcare By Technology (USD Million, 2026-2035)

Neurostimulation Devices
Surgical Navigation Systems
Imaging Techniques
Robotic Surgery

Healthcare By Healthcare Setting (USD Million, 2026-2035)

Hospitals
Specialized Epilepsy Centers
Outpatient Clinics

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”